Phospho-LCK (Y192) Antibody

Shipped with Ice Packs
In Stock

Description

Mechanism of Action

The Y192 site in Lck’s SH2 domain is dynamically phosphorylated in response to TCR engagement, functioning as part of a negative feedback loop. Phosphorylation at Y192 prevents the phosphatase CD45 from dephosphorylating Lck’s inhibitory C-terminal tail (Y505), thereby stabilizing Lck in its inactive conformation . This regulation ensures precise control over TCR signaling thresholds, balancing activation and tolerance. The Phospho-LCK (Y192) Antibody enables direct visualization and quantification of this phosphorylation event in cells or tissues.

2.1. TCR Signaling Modulation

  • Jurkat T Cells: Studies using Jurkat T cells reconstituted with Lck Y192E (phospho-mimetic) or Y192A (non-phosphorylatable) mutants revealed that Y192 phosphorylation correlates with attenuated calcium flux and Zap70 activation. Y192E/A variants exhibited delayed and reduced signaling compared to wild-type Lck .

  • Primary T Cells: Knock-in mice harboring Y192E mutations showed hyperphosphorylation of Y505, impaired thymocyte development, and defective TCR-mediated proliferation .

2.2. Thymocyte Development

Thymic analysis of Lck Y192E mice demonstrated a developmental block at the β-selection checkpoint, with reduced numbers of double-negative (DN) thymocytes and impaired Erk1/2 activation . This defect mirrored CD45 deficiency, underscoring Y192’s role in regulating Lck activity during thymopoiesis .

2.3. Kinase Activity

In vitro kinase assays revealed that Lck Y192E retains enzymatic activity comparable to wild-type Lck, suggesting that Y192 primarily regulates Lck localization and substrate access rather than intrinsic catalytic function .

Applications of the Antibody

The Phospho-LCK (Y192) Antibody is employed in:

  1. Western Blotting: To monitor Y192 phosphorylation in response to TCR stimulation or kinase inhibitors (e.g., PP2).

  2. Immunoprecipitation: To isolate phosphorylated Lck for downstream analysis of interacting proteins (e.g., CD45, Zap70).

  3. Flow Cytometry: To assess Y192 phosphorylation in primary T cells or thymocytes during development.

  4. Immunohistochemistry: To localize phosphorylated Lck in tissues, aiding studies of immune regulation or lymphoid malignancies .

Clinical Relevance

Phospho-LCK (Y192) Antibody is critical for studying immune dysregulation. Aberrant Y192 phosphorylation has been implicated in:

  • Immunodeficiency: Defects in Y192 regulation may impair T-cell activation, increasing susceptibility to infections .

  • Leukemia: Lck hyperactivation due to Y192 mutations could contribute to oncogenic signaling in T-cell malignancies .

  • Immunotherapy: Understanding Y192 dynamics may inform strategies to enhance anti-tumor T-cell responses .

Product Specs

Buffer
Liquid in PBS containing 50% glycerol, 0.5% BSA, and 0.02% sodium azide.
Form
Liquid
Lead Time
Generally, we can ship the products within 1-3 business days after receiving your orders. Delivery time may vary depending on the purchasing method or location. Please consult your local distributors for specific delivery time details.
Synonyms
IMD22 antibody; LCK antibody; Lck p56 antibody; LCK proto-oncogene; Src family tyrosine kinase antibody; LCK_HUMAN antibody; Leukocyte C-terminal Src kinase antibody; LSK antibody; Lymphocyte cell specific protein tyrosine kinase antibody; Lymphocyte cell-specific protein-tyrosine kinase antibody; Lymphocyte specific protein tyrosine kinase antibody; Membrane associated protein tyrosine kinase antibody; Oncogene lck antibody; P56 LCK antibody; p56(LSTRA) protein tyrosine kinase antibody; p56-LCK antibody; p56lck antibody; pp58 lck antibody; pp58lck antibody; Protein YT16 antibody; Proto oncogene tyrosine protein kinase LCK antibody; Proto-oncogene Lck antibody; Protooncogene tyrosine protein kinase LCK antibody; T cell specific protein tyrosine kinase antibody; T cell-specific protein-tyrosine kinase antibody; T lymphocyte specific protein tyrosine kinase p56lck antibody; Tyrosine-protein kinase Lck antibody; YT 16 antibody; YT16 antibody
Target Names
LCK
Uniprot No.

Target Background

Function
Lck, a non-receptor tyrosine-protein kinase, plays a critical role in the selection and maturation of developing T cells in the thymus and in the function of mature T cells. It is essential for T-cell antigen receptor (TCR)-linked signal transduction pathways. Lck is constitutively associated with the cytoplasmic portions of the CD4 and CD8 surface receptors. When the TCR interacts with a peptide antigen-bound MHC complex, it facilitates the interaction of CD4 and CD8 with MHC class II and class I molecules, respectively, recruiting the associated Lck protein to the TCR/CD3 complex. Lck then phosphorylates tyrosine residues within the immunoreceptor tyrosine-based activation motifs (ITAM) of the cytoplasmic tails of the TCR-gamma chains and CD3 subunits, initiating the TCR/CD3 signaling pathway. Upon stimulation, the TCR recruits the tyrosine kinase ZAP70, which is subsequently phosphorylated and activated by Lck. This triggers a cascade of signaling molecule recruitment, ultimately leading to lymphokine production. Lck also contributes to signaling by other receptor molecules. It directly associates with the cytoplasmic tail of CD2, leading to hyperphosphorylation and activation of Lck. Additionally, it plays a role in the IL2 receptor-linked signaling pathway, which controls the T-cell proliferative response. Binding of IL2 to its receptor results in increased Lck activity. Lck is expressed at all stages of thymocyte development and is crucial for regulating maturation events governed by both pre-TCR and mature alpha beta TCR. It phosphorylates other substrates, including RUNX3, PTK2B/PYK2, the microtubule-associated protein MAPT, RHOH or TYROBP. Lck interacts with FYB2.
Gene References Into Functions
  1. The ionic CD3-epsilon -Lck interaction controls the phosphorylation level of the T-cell receptor. PMID: 28659468
  2. PLC-gamma1 plays a previously unappreciated role in positively regulating Zap-70 and T-cell receptor tyrosine phosphorylation. Conversely, PLC-gamma1 negatively regulated the phosphorylation of SLP-76-associated proteins, including established Lck substrate phosphorylation sites within this complex. PMID: 28644030
  3. Autophosphorylation of the Lck active-site loop is essential for its catalytic activity. Lck can stimulate its own activation by adopting a more open conformation, which can be modulated by point mutations. Furthermore, CD4 and CD8, T-cell coreceptors, can enhance Lck activity. PMID: 29083415
  4. The central biological role of the novel IL-2-R/Lck/PLCgamma/PKCtheta;/alphaPIX/Rac1/PYGM signaling pathway is directly related to the control of fundamental cellular processes such as T cell migration and proliferation. PMID: 27519475
  5. Possible models of regulation of Lck by Aurora-A during T cell activation are described in the review. PMID: 27910998
  6. Mutation of the basic clusters in the CD28 cytoplasmic domain reduced the recruitment to the CD28-Lck complex of protein kinase Ctheta; (PKCtheta;), which serves as a key effector kinase in the CD28 signaling pathway. PMID: 27460989
  7. Data suggest that T cell activation through the TCR complex is accompanied by the de novo activation of T-lymphocyte specific protein tyrosine kinase p56lck (Lck) and that phosphorylation of Tyr(394) plays a role in Lck function that goes beyond inducing an open conformation of the kinase. PMID: 28096507
  8. WASH has a pivotal role for regulation of NK cell cytotoxicity through Lck-mediated Y141 tyrosine phosphorylation. PMID: 27441653
  9. A phosphosite within the SH2 Domain of Lck regulates its activation by CD45. A negative feedback loop that responds to signaling events tunes active Lck amounts and TCR sensitivity. PMID: 28735895
  10. The results have revealed a novel splicing homozygous mutation of LCK that may be responsible for the clinical phenotype of HPV infection from latency to invasive carcinoma. PMID: 27087313
  11. This study shows that Lck acts as a major signaling hub of CD147 in T cells. PMID: 28148733
  12. Data indicate that HSP65 suppresses cholesterol efflux and increases cellular cholesterol content through an Lck-mediated pathway in T cells. PMID: 27742830
  13. LSKlow cells, which are derived from LSK cells in p18(-/-) mice, possess lymphoid differentiation ability and short-term repopulation capability. PMID: 27287689
  14. These results suggest that PM lipids, including phosphatidylinositol 4,5-bisphosphate and phosphatidylinositol 3,4,5-trisphosphate, modulate interaction of Lck with its binding partners in the TCR signaling complex and its TCR signaling activities in a spatiotemporally specific manner via its SH2 domain. PMID: 27334919
  15. This study shows that p56(lck), which is essential for activation of T cells through the T-cell receptor, is also critical for signal transduction through Toll-like receptors in T cells. PMID: 26888964
  16. Aurora A inhibition causes delocalized clustering of Lck at the immunological synapses and decreases its phosphorylation levels, indicating that Aurora A is required for maintaining Lck active during T-cell activation. PMID: 27091106
  17. Results demonstrate that Lck represses oxidative phosphorylation through competitive binding with mitochondrial CRIF1 in a kinase-independent manner. PMID: 26210498
  18. Introducing bulky side-chains into this patch (GGxxG to GVxxL) impairs the Lck-independent role of CD4 in T cell activation upon TCR engagement of agonist and weak agonist stimulation. PMID: 26147390
  19. Our results support a novel function of nuclear Lck in promoting human leukemic T cell survival through interaction with a tumor suppressor, CRIF1. PMID: 25997448
  20. TSAD binds to and co-localizes with Nck. Expression of TSAD increases both Nck-Lck and Nck-SLP-76 interaction in T cells. PMID: 26163016
  21. These findings demonstrate highly dynamic Lck palmitoylation kinetics that are essential for signaling downstream of the Fas receptor. PMID: 26351666
  22. Cells from PAX5 translocated patients show LCK up-regulation and over-activation, as well as STAT5 hyper-phosphorylation, compared to PAX5 wt and PAX5 deleted cases. PMID: 25595912
  23. T cell receptor (TCR)-CD3 complex and the Lck kinase were required for Ca(2+) mobilization but not for apoptosis induction in Jurkat cells. PMID: 25947381
  24. In T-cells, cholesterol-dependent domains function in the regulation of the Src family kinase Lck (p56lck) by sequestering Lck from its activator CD45. (Review) PMID: 25658353
  25. Phosphatase CD45 both positively and negatively regulates T cell receptor phosphorylation in reconstituted membrane protein clusters, depending on LCK activity. PMID: 25128530
  26. Lck is retained in the cytosol of CD222-deficient cells, which obstructs the recruitment of Lck to CD45 at the cell surface, resulting in an abundant inhibitory phosphorylation signature on Lck at the steady state. PMID: 25127865
  27. Lck mediates signal transmission from CD59 to the TCR/CD3 pathway in Jurkat T cells. PMID: 24454946
  28. NUP214-ABL1-mediated cell proliferation in T-cell acute lymphoblastic leukemia is dependent on the LCK kinase and various interacting proteins. PMID: 23872305
  29. LCK phosphorylated Tyr-342 of FOXP3 by immunoprecipitation and in vitro kinase assay, and the replacement of Tyr-342 with phenylalanine (Y342F) abolished the ability to suppress MMP9 expression. PMID: 24155921
  30. Our data reveal how SAP nucleates a previously unknown signaling complex involving NTB-A and LCK to potentiate restimulation-induced cell death of activated human T cells. PMID: 24688028
  31. Data show a major role for LCK in proximal and distal BCR-mediated signaling in CLL cells and suggest that LCK expression is important in the pathogenesis of CLL. PMID: 23505068
  32. Nef thus interferes with a specialized membrane microdomain-associated pathway for plasma membrane delivery of newly synthesized Lck whose specificity is determined by the affinity of cargo for these sorting platforms. PMID: 23601552
  33. In the absence of FAK, the inhibitory phosphorylation of Lck is impaired. PMID: 24227778
  34. Spatial regulation of Lck by CD45 and GM1 ganglioside determines the outcome of apoptotic response to Gal-1, and this local regulation may occur only upon intimate effector (Gal-1 expressing) cell-T-cell attachment. PMID: 24231767
  35. VP11/12 SFK-binding motifs recruit Lck, and the activated Src family kinase then leads (directly or indirectly) to phosphorylation of additional motifs involved in recruiting p85, Grb2, and Shc. PMID: 23946459
  36. LCK (lymphocyte-specific protein tyrosine kinase) plays a crucial role in T-cell response by transducing early activation signals triggered by TCR (T-cell receptor) engagement. [REVIEW] PMID: 23931554
  37. Conformational states regulate clustering in early T cell signaling. PMID: 23202272
  38. T-cell receptor-induced stimulation of T cells led to simultaneous phosphorylation of p56(lck) residues. PMID: 22674786
  39. LCK-positive tumor infiltrate is associated with a significantly longer overall survival and time to relapse in patients with radically resected stage I NSCLC. PMID: 22457183
  40. Data show that cytoskeletal modulation of lipid interactions regulates Lck kinase activity. PMID: 22613726
  41. Increases in Ca(2+) lead to CaMKII activation and subsequent Lck-dependent p66Shc phosphorylation on Serine 36. This event causes both mitochondrial dysfunction and impaired Ca(2+) homeostasis, which synergize in promoting Jurkat T-cell apoptosis. PMID: 21983898
  42. The Kv1.3/Dlg1/Lck complex is part of the membrane pathway utilized by cyclic AMP to regulate T-cell function. PMID: 22378744
  43. DHHC2 localizes primarily to the endoplasmic reticulum and Golgi apparatus, suggesting that it is involved in S-acylation of newly-synthesized or recycling Lck involved in T cell signaling. PMID: 22034844
  44. The segment comprising residues 112-126 of human LAT is required for its interaction with Lck. PMID: 22034845
  45. Feedback circuits monitor and adjust basal Lck-dependent events in T cell receptor signaling. PMID: 21917715
  46. These results showed that MG132-induced apoptosis was caused by ER stress and subsequent activation of the mitochondria-dependent caspase cascade; the presence of p56(lck) enhances MG132-induced apoptosis by augmenting ER stress-mediated apoptotic events. PMID: 21819973
  47. Data show that MAL regulates membrane order and the distribution of microtubule and transport vesicle docking machinery at the IS, ensuring correct protein sorting of Lck and LAT to the cSMAC. PMID: 21508261
  48. Deregulations of Lck-ZAP-70-Cbl-b cross-talk and miR181a in T cells were found to be associated with cholesterol-dependent-dismantling of HLA-DR rafts in macrophages in leprosy progression. PMID: 21453975
  49. Preactivated Lck is both necessary and sufficient for T cell activation but remains uncoupled from the T cell receptor in the absence of antigen. PMID: 21266711
  50. Suppressor of cytokine signaling 1 interacts with oncogenic lymphocyte-specific protein tyrosine kinase. PMID: 21234523

Show More

Hide All

Database Links

HGNC: 6524

OMIM: 153390

KEGG: hsa:3932

STRING: 9606.ENSP00000337825

UniGene: Hs.470627

Involvement In Disease
Immunodeficiency 22 (IMD22)
Protein Families
Protein kinase superfamily, Tyr protein kinase family, SRC subfamily
Subcellular Location
Cell membrane; Lipid-anchor; Cytoplasmic side. Cytoplasm, cytosol.
Tissue Specificity
Expressed specifically in lymphoid cells.

Q&A

What is LCK Y192 phosphorylation and why is it important in T cell signaling?

LCK (Lymphocyte-specific protein tyrosine kinase) is a Src Family Kinase (SFK) that sets a critical threshold for T cell activation by phosphorylating the TCR complex and the Zap70 kinase. Y192 is a tyrosine residue located within the SH2 domain of LCK that serves as an underappreciated regulatory phosphosite conserved amongst all human SFKs . Phosphorylation at Y192 profoundly affects the amount of active LCK in cells, thereby influencing TCR sensitivity .

Research has demonstrated that modification of Y192 inhibits the ability of CD45 to associate with LCK in cells and dephosphorylate the C-terminal tail, preventing LCK from adopting an active open conformation . This represents a negative feedback mechanism that responds to signaling events to tune active LCK amounts and TCR sensitivity, making it crucial for proper T cell function and development .

How does Y192 phosphorylation differ from the conventional regulatory sites on LCK?

The conventional view of SFK regulation has focused on two tyrosine phosphorylation sites: Y394 (activation loop) and Y505 (C-terminal tail) . Y394 phosphorylation promotes the active conformation of LCK, with studies showing that the free LCK pool exhibits more activating Y394 phosphorylation than coreceptor-bound LCK . Conversely, Y505 phosphorylation promotes the closed, inactive conformation through intramolecular binding to LCK's own SH2 domain.

Y192 phosphorylation represents a third critical regulatory mechanism that functions differently than the other two sites . Unlike direct conformational control, Y192 phosphorylation alters the binding specificity of the SH2 domain and inhibits the association of LCK with phosphatases like CD45 . This leads to hyperphosphorylation of the inhibitory C-terminal tail (Y505), indirectly maintaining LCK in an inactive state through a sophisticated regulatory circuit .

Which kinases are responsible for phosphorylating LCK at Y192?

Several kinases have been implicated in Y192 phosphorylation, suggesting a complex regulatory network:

  • Zap70: Selective inhibition of Zap70 leads to a pronounced decrease in Y192 phosphorylation in both resting and activated T cells, along with increased phosphorylation of the LCK-activating tyrosine 394 (Y394) .

  • ITK: This Tec family tyrosine kinase located downstream of Zap70 has been implicated in Y192 phosphorylation . ITK, along with Syk and Zap70, has previously been identified as potentially responsible for this modification .

  • Zap70-mediated pathways: Since Zap70 is an LCK substrate, this relationship suggests a negative feedback loop wherein LCK activates Zap70, which then directly or indirectly leads to phosphorylation of LCK at Y192, thereby dampening LCK activity .

This multi-kinase involvement highlights the sophisticated nature of LCK regulation and the central role of Y192 in feedback control mechanisms within T cell signaling.

What are the optimal methods for detecting and quantifying LCK Y192 phosphorylation?

For reliable detection and quantification of LCK Y192 phosphorylation, researchers should consider these validated approaches:

Western blotting with specific antibodies represents the most common method, where Lck phosphorylation status can be reported by the intensity ratio of pY394-Lck (active Lck)/Y394-nonphospho-Lck (inactive Lck) . When using this approach, it's crucial to supplement lysis buffer with SFK inhibitor PP2 (20 μM) together with a protease-phosphatase inhibitor mixture during cell lysis and immunoprecipitation to maintain Lck phosphorylation status .

For quantification, the LI-COR fluorescent imaging system enables accurate measurement of intensity ratios between different phosphorylated forms on the same immunoblots . This approach has been successfully validated by showing that treatment with pervanadate (phosphatase inhibitor) increases the pY394/Y394-nonphospho ratio, while PP2 (SFK inhibitor) decreases it .

Alternative approaches include FRET-based biosensors such as ZapLck, which can visualize Lck kinase activity with high spatiotemporal resolution in live cells . While not directly measuring Y192 phosphorylation, these biosensors can detect functional consequences of Y192 phosphorylation status in real-time.

How can I validate the specificity of a Phospho-LCK (Y192) antibody?

When validating a Phospho-LCK (Y192) antibody, implement these critical controls:

  • Y192F mutation comparison: The most definitive validation involves comparing antibody reactivity between wild-type LCK and LCK with a Y192F mutation . The Y192F mutant cannot be phosphorylated at position 192 and should show no reactivity with a phospho-specific antibody.

  • Phosphatase treatment: Treat cell lysates with phosphatases to remove phosphorylation and confirm the loss of antibody reactivity. Conversely, treatment with pervanadate (phosphatase inhibitor) should increase the signal if the antibody is phospho-specific .

  • Kinase inhibitor treatments: Treatment with Zap70 inhibitors should decrease Y192 phosphorylation if the antibody is specific, as Zap70 inhibition leads to a pronounced decrease in Y192 phosphorylation .

  • Stimulus-dependent changes: Verify that antibody reactivity changes appropriately with TCR stimulation, consistent with the known biology of Y192 phosphorylation .

Multiple validation approaches should be used in conjunction to ensure antibody specificity before proceeding with experimental studies.

What controls should be included when studying the functional effects of Y192 phosphorylation?

To comprehensively assess the functional consequences of Y192 phosphorylation, include these essential controls:

  • Y192F mutant: This mutant prevents phosphorylation at position 192 and serves as a crucial negative control . Studies have shown that Y192F mutation blocks critical TCR proximal signaling events and impairs thymocyte development in retrogenic mice .

  • Y505F mutant: This constitutively active form of LCK provides a comparison point for distinguishing between different regulatory mechanisms . Researchers have demonstrated that Y192F-induced clustering is fundamentally different from Y505F-induced clustering, with Y192F clusters being more numerous but having very low density compared to the fewer but denser Y505F clusters .

  • Comparison with other phosphorylation sites: Always monitor Y394 and Y505 phosphorylation alongside Y192 to understand the interrelationship between different regulatory mechanisms . This is particularly important as these sites form part of an integrated regulatory system.

  • Signaling downstream: Measure functional outcomes such as TCR phosphorylation, calcium flux, and cytokine production to connect Y192 phosphorylation status with T cell function .

These controls enable researchers to distinguish the specific effects of Y192 phosphorylation from other regulatory mechanisms affecting LCK activity.

How does Y192 phosphorylation regulate LCK clustering and spatial distribution?

Y192 phosphorylation significantly impacts LCK's spatial organization in the plasma membrane of T cells through distinct mechanisms:

The molecular basis for this difference appears to involve protein-protein interactions mediated by the SH2 domain rather than conformational changes . Y192 phosphorylation modifies the binding specificity of the LCK SH2 domain, affecting its interaction with various signaling partners.

Scientists have proposed that the "declustering" of LCK when Y192 is phosphorylated may represent a mechanism for downregulating LCK signaling, similar to what has been described for Zap70 clusters . Alternatively, it could function as a way of "recycling" the LCK population engaged in clusters, either to allow LCK molecules to search for more triggered TCRs or to engage in other processes related to later T cell signaling events .

What protein interactions are affected by Y192 phosphorylation?

Y192 phosphorylation significantly alters LCK's interaction landscape, functioning as a molecular switch that regulates the binding specificity of the SH2 domain:

These altered interactions collectively contribute to a sophisticated regulatory mechanism that helps fine-tune T cell signaling responses through control of active LCK levels.

How does Y192 phosphorylation participate in feedback regulation of TCR signaling?

Y192 phosphorylation functions within a sophisticated negative feedback loop that modulates TCR signaling thresholds:

The mechanism begins with TCR stimulation activating LCK, which phosphorylates ITAMs on the TCR complex and Zap70 . Activated Zap70 (directly or via ITK) then phosphorylates LCK at Y192 . This phosphorylation inhibits CD45 association with LCK, preventing dephosphorylation of the inhibitory Y505 site . Consequently, Y505 remains phosphorylated, promoting the closed, inactive LCK conformation and reducing the pool of active LCK .

This feedback circuit is physiologically significant - mutation of Y192 (Y192F) blocks critical TCR proximal signaling events and impairs thymocyte development in retrogenic mice . The Y192F defects are caused by hyperphosphorylation of the activating Y394 site, consistent with disruption of the negative feedback loop .

Studies using FRET biosensors have shown that up to 62% of LCK may be preactivated in Jurkat cells, with LckY394F almost completely abolishing this preactivation . This suggests that Y394 phosphorylation, regulated in part through Y192 phosphorylation, is critical for maintaining appropriate levels of active LCK in resting and stimulated T cells .

What is the relationship between Zap70 and LCK Y192 phosphorylation?

Zap70 and LCK form a bidirectional regulatory circuit involving Y192 phosphorylation:

Selective inhibition of Zap70 leads to a pronounced decrease in Y192 phosphorylation in both resting and activated T cells . This coincides with increased phosphorylation of the LCK-activating tyrosine 394 (Y394), consistent with a model where Y192 phosphorylation negatively regulates LCK activity .

The molecular mechanism involves several interdependent steps: LCK phosphorylates the ITAM domains of the TCR complex, creating docking sites for Zap70 . LCK then further phosphorylates Zap70 at residues Y315 and Y319, inducing Zap70 activation . LCK subsequently binds to phosphorylated Y319 on Zap70, an event that stabilizes the activated conformation of LCK and facilitates further Zap70 activation .

Once activated, Zap70 phosphorylates the adaptor protein LAT, which contributes to LCK phosphorylation at Y394 upon TCR stimulation . LAT also interacts with LCK upon TCR activation and preferentially associates with the open form of LCK .

This reciprocal relationship creates a regulatory circuit where LCK activates Zap70, which then feeds back to regulate LCK activity through Y192 phosphorylation, helping to fine-tune T cell receptor sensitivity.

How does the Y192F mutation affect T cell function and development?

The Y192F mutation, which prevents phosphorylation at this regulatory site, has profound effects on T cell function and development:

Studies in retrogenic mice have demonstrated that the Y192F mutation impairs thymocyte development, establishing the physiological importance of Y192 phosphorylation in vivo . At the molecular level, Y192F mutation blocks critical TCR proximal signaling events by disrupting the negative feedback loop that regulates LCK activity .

The mutation causes hyperphosphorylation of the activating Y394 site and increases TCR phosphorylation, suggesting enhanced LCK activity . This is consistent with the model where Y192 phosphorylation normally serves to dampen LCK activity as part of a negative feedback mechanism .

Research also shows that Y192F mutation significantly alters LCK clustering patterns, with Y192F mutants forming more numerous but less dense clusters compared to both wild-type LCK and constitutively active Y505F LCK . These clustering differences likely contribute to the altered signaling properties of Y192F LCK.

The developmental defects observed with Y192F mutation highlight how precise regulation of LCK activity through Y192 phosphorylation is essential for establishing appropriate signaling thresholds during T cell development, where TCR signal strength determines positive and negative selection outcomes.

What are the key technical considerations when studying LCK Y192 phosphorylation?

When investigating LCK Y192 phosphorylation, researchers should be aware of several critical technical considerations:

  • Preserving phosphorylation status: LCK can transautophosphorylate its Y394 site even after cell lysis, potentially confounding results . To maintain LCK phosphorylation status accurately, supplement lysis buffer with SFK inhibitor PP2 (20 μM) together with a protease-phosphatase inhibitor mixture during cell lysis and immunoprecipitation incubation .

  • Antibody validation: Use multiple approaches to validate phospho-specific antibodies, including Y192F mutants as negative controls, and treatments with phosphatase inhibitors (pervanadate) or SFK inhibitors (PP2) as positive and negative controls respectively .

  • Quantification methods: For accurate quantification, calculate the intensity ratio of phosphorylated versus non-phosphorylated forms using systems like the LI-COR fluorescent imaging system . This approach has been validated by showing appropriate ratio changes with phosphatase or kinase inhibitors .

  • Cell system selection: Different experimental systems have distinct advantages - JCam cell lines reconstituted with wild-type or mutant LCK provide a clean background for molecular studies , while primary T cells and in vivo models are essential for confirming physiological relevance .

  • Dynamic measurements: Given the dynamic nature of Y192 phosphorylation, consider time-course experiments and live-cell imaging approaches like FRET biosensors to capture temporal regulation .

These technical considerations ensure reliable and reproducible results when studying this critical regulatory mechanism in T cell signaling.

How can I design experiments to test the functional significance of Y192 phosphorylation?

To comprehensively assess the functional significance of Y192 phosphorylation in T cell biology, implement these experimental approaches:

  • Comparative mutational analysis: Express wild-type LCK alongside Y192F (preventing phosphorylation) and Y192E (potential phosphomimetic) mutants in LCK-deficient cells like JCam1.6 . Compare these with other regulatory mutants like Y505F (constitutively active) to distinguish between different regulatory mechanisms .

  • Signaling cascade analysis: Measure proximal TCR signaling events (ITAM phosphorylation, Zap70 activation) and downstream outcomes (calcium flux, NFAT activation, cytokine production) to establish the consequences of Y192 phosphorylation across the signaling pathway .

  • Protein interaction studies: Use techniques like co-immunoprecipitation, proximity ligation assays, or FRET-based approaches to investigate how Y192 phosphorylation affects LCK's interactions with key partners like CD45, TSAd, and SHP-1 .

  • Advanced imaging approaches: Employ super-resolution microscopy techniques like PALM to visualize how Y192 phosphorylation affects LCK clustering and spatial organization in the plasma membrane . Complement with FRET biosensors to monitor LCK activity in real-time .

  • In vivo models: Use retrogenic mice expressing wild-type or Y192F LCK to assess developmental consequences and immune function in a physiological context .

This multi-faceted approach will provide comprehensive insights into how Y192 phosphorylation regulates LCK function across different biological contexts.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.